Li‐Mei Chen

Fudan University — China

Medicine · Health Sciences

35h-index5.2kcitations128works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cervical Cancer and HPV Research(13), Influenza Virus Research Studies(12), Language Development and Disorders(11), Protease and Inhibitor Mechanisms(10), Cell Adhesion Molecules Research(10)

Publications127 total

Clinical application of hysteroscopic decidual polypectomy in pregnant women
2025Open Access
Nuclear-localized metabolic enzymes: emerging key players in tumor epigenetic regulation
Molecular and Cellular Biochemistry·2025
[Efficacy of selinexor combined with subcutaneous decitabine in myeloid malignancies refractory to or relapsed after venetoclax therapy].
PubMed·2025Open Access
AI-Based Optimization of Novel Combined IBD+ND Live Vaccine Dosage
2025
The application of magnifying endoscopy in the diagnosis of cervical lesions
Heliyon·2025Open Access
Colposcopic Imaging Features and Missed Diagnoses in Cervical Adenocarcinoma In Situ: A Retrospective Study
2024Open Access
646P Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for epidermal growth factor receptor inhibitor (EGFRi)-resistant, EGFR-mutant, advanced non-small cell lung cancer (NSCLC): Updated results from Cohort 5 in the DUBHE-L-201 study
Annals of Oncology·2024· 1 cited
The application of magnifying endoscopy in the diagnosis of cervical lesions
2024Open Access
Comparing the Effects of Paclitaxel Liposomes and Albumin-Bound Paclitaxel on the Tumor Regression Rate among Cervical Cancer Patients Undergoing Concurrent Radiotherapy
International Journal of Radiation Oncology*Biology*Physics·2024
13P Tislelizumab (TIS) plus chemotherapy (chemo) with or without bevacizumab (beva) for patients with EGFR-mutated nonsquamous non-small cell lung cancer (nsq-NSCLC) after progression on EGFR tyrosine kinase inhibitor (TKI) therapy
ESMO Open·2024Open Access
Design, synthesis and evaluation of C-5 substituted pyrrolopyridine derivatives as potent Janus Kinase 1 inhibitors with excellent selectivity
European Journal of Medicinal Chemistry·2024· 4 citedOpen Access
Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer
Theranostics·2024· 19 citedOpen Access
The Application of Magnifying Endoscopy in the Diagnosis of Cervical  Lesions
SSRN Electronic Journal·2024Open Access
Functional and metabolic alterations of gut microbiota in children with new-onset type 1 diabetes
Yearbook of pediatric endocrinology·2023· 2 cited
Exosome-Mediated Activation of the Prostasin-Matriptase Serine Protease Cascade in B Lymphoma Cells
Cancers·2023· 2 citedOpen Access
Prostasin in Human Health and Disease
WORLD SCIENTIFIC eBooks·2022· 3 cited
Research trends and hotspots on human papillomavirus: a bibliometric analysis of 100 most-cited articles
Annals of Translational Medicine·2022· 4 citedOpen Access
A novel antibody-TCR (AbTCR) T-cell therapy is safe and effective against CD19-positive relapsed/refractory B-cell lymphoma
Journal of Cancer Research and Clinical Oncology·2022· 15 citedOpen Access
Targeting prooxidant MnSOD effect inhibits triple-negative breast cancer (TNBC) progression and M2 macrophage functions under the oncogenic stress
Cell Death and Disease·2022· 42 citedOpen Access
Crystalline H-aggregate nanoparticles for detecting dopamine release from M17 human neuroblastoma cells
Journal of Materials Chemistry B·2022
page 1 of 7Next →

Frequent Co-authors

Karl X. Chai(17), Rubén O. Donis(9), Mengqian Chen(6), Nancy J. Cox(4), Hong‐Yu Tseng(4), Aushia Tanzih Al Haq(4), Hsin-Ling Hsu(4), Long Sui(4), Chen‐Yong Lin(4), Taronna R. Maines(3), Jacqueline M. Katz(3), Yen‐An Chen(3), Julie Chao(3), Lee Chao(3), Aleksandr S. Lipatov(3), C. Todd Davis(3), Ya‐Yuan Fu(3), Sandra Pérez(2), Hongquan Wan(2), Terrence M. Tumpey(2)